Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA)

Historical Holders from Q1 2014 to Q3 2025

Symbol
VNDA on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
58.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
44.9M
Holdings value
$224M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
147
Number of buys
71
Number of sells
-64
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.1% -46.9% $20.2M -$18.9M 4.7M -48.4% BlackRock, Inc. 31 Jan 2025
BlackRock Portfolio Management LLC 7.7% $19.3M 4.48M BlackRock Portfolio Management LLC 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 5.3% $13.5M 3.12M Millennium Management LLC 27 Jun 2025

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock, par value $0.001 per share (VNDA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 44.9M $224M -$589K $4.99 147
2025 Q2 45M $212M +$5.36M $4.72 137
2025 Q1 43.9M $202M +$2.28M $4.59 145
2024 Q4 43.1M $207M -$5.83M $4.79 146
2024 Q3 44M $206M +$385K $4.69 151
2024 Q2 43.5M $246M -$20.2M $5.65 147
2024 Q1 48.1M $197M -$11.4M $4.11 140
2023 Q4 50.7M $214M -$8.17M $4.22 154
2023 Q3 52.6M $227M -$23M $4.32 179
2023 Q2 56.2M $371M -$14.3M $6.59 187
2023 Q1 58.3M $396M +$17.2M $6.79 176
2022 Q4 55.6M $411M +$2.19M $7.39 186
2022 Q3 55.1M $545M -$11.3M $9.88 171
2022 Q2 56M $611M -$187K $10.90 166
2022 Q1 56.3M $637M +$17.4M $11.31 181
2021 Q4 54.3M $851M -$29.8M $15.69 192
2021 Q3 55.2M $947M +$4.38M $17.14 173
2021 Q2 54.8M $1.18B +$10.4M $21.51 176
2021 Q1 54.5M $820M -$4.49M $15.02 182
2020 Q4 55M $723M +$5.52M $13.14 170
2020 Q3 54.4M $526M -$8.61M $9.66 159
2020 Q2 55.1M $631M +$15.6M $11.44 159
2020 Q1 53.8M $557M +$130K $10.36 154
2019 Q4 52.8M $867M -$1.38M $16.41 170
2019 Q3 53M $703M -$21.6M $13.28 161
2019 Q2 54.3M $765M +$13.8M $14.09 158
2019 Q1 54.4M $1B +$5.34M $18.40 175
2018 Q4 53M $1.38B +$27.8M $26.13 180
2018 Q3 52.2M $1.2B +$80M $22.95 157
2018 Q2 49M $934M +$18.6M $19.05 134
2018 Q1 48.2M $812M +$129M $16.85 130
2017 Q4 40.9M $621M +$12M $15.20 125
2017 Q3 39.7M $711M +$17.2M $17.90 137
2017 Q2 38.9M $633M -$6.54M $16.30 131
2017 Q1 39.7M $556M +$44.1M $14.00 134
2016 Q4 40.6M $648M -$10.2M $15.95 141
2016 Q3 40.8M $678M +$66.6M $16.64 137
2016 Q2 37.2M $417M -$42.2M $11.19 115
2016 Q1 41.3M $345M -$12.8M $8.36 115
2015 Q4 42.6M $396M -$31.5M $9.31 116
2015 Q3 42.7M $482M +$466K $11.28 121
2015 Q2 42.4M $538M -$35.4M $12.69 109
2015 Q1 46.3M $431M -$27.5M $9.30 108
2014 Q4 47.7M $682M +$77.1M $14.32 108
2014 Q3 41.3M $429M +$24.2M $10.38 101
2014 Q2 38.5M $622M +$52.9M $16.18 110
2014 Q1 35.2M $571M +$57.3M $16.25 109